Tenofovir disoproxil (Compound)

Compound:

tenofovir disoproxil (0d7c4075-4518-402b-b2bc-706eea75c139)

Synonyms:Tenofovir disoproxil, 201341-05-1, PMPA prodrug, Bis(POC)PMPA, (r)-bis(poc)pmpa, bis-POC-PMPA, 9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine, tenofovir bis(isopropyloxycarbonyloxymethyl) ester, UNII-F4YU4LON7I, F4YU4LON7I

Pubchem:PUBCHEM:5481350

Id:b482bb28-34b6-5ebe-9105-1cdb26fdf15f

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Tenofovir disoproxil's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Tenofovir disoproxil.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Tenofovir disoproxil.

Results found

Linked to

	Label	Description
	tenofovir disoproxil (0d7c4075-4518-402b-b2bc-706eea75c139) Collection (Entity type)	Metadatata for tenofovir disoproxil
	Tenofovir disoproxil indication Hepatitis B, Chronic Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Tenofovir disoproxil indication HIV Infections Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

tenofovir disoproxil (0d7c4075-4518-402b-b2bc-706eea75c139)

Collection (Entity type)

Metadatata for tenofovir disoproxil

Tenofovir disoproxil indication Hepatitis B, Chronic

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Tenofovir disoproxil indication HIV Infections

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.